WORK Medical Technology Group LTD Announces Implementation of Dual-Class Share Structure Effective March 6, 2025
WORK Medical Technology Group (Nasdaq: WOK), a medical device supplier operating through its subsidiary Work (Hangzhou) Medical Treatment Equipment Co. in China, has announced the implementation of a dual-class share structure. The new share structure will take effect on March 6, 2025.
WORK Medical Technology Group (Nasdaq: WOK), un fornitore di dispositivi medici che opera attraverso la sua controllata Work (Hangzhou) Medical Treatment Equipment Co. in Cina, ha annunciato l'implementazione di una struttura azionaria a doppia classe. La nuova struttura azionaria entrerà in vigore il 6 marzo 2025.
WORK Medical Technology Group (Nasdaq: WOK), un proveedor de dispositivos médicos que opera a través de su filial Work (Hangzhou) Medical Treatment Equipment Co. en China, ha anunciado la implementación de una estructura de acciones de doble clase. La nueva estructura de acciones entrará en vigor el 6 de marzo de 2025.
WORK Medical Technology Group (Nasdaq: WOK), 중국의 Work (Hangzhou) Medical Treatment Equipment Co.를 통해 운영되는 의료 기기 공급업체가 이중 클래스 주식 구조의 구현을 발표했습니다. 새로운 주식 구조는 2025년 3월 6일에 시행될 예정입니다.
WORK Medical Technology Group (Nasdaq: WOK), un fournisseur de dispositifs médicaux opérant par l'intermédiaire de sa filiale Work (Hangzhou) Medical Treatment Equipment Co. en Chine, a annoncé la mise en œuvre d'une structure d'actions à double classe. La nouvelle structure d'actions prendra effet le 6 mars 2025.
WORK Medical Technology Group (Nasdaq: WOK), ein Anbieter von medizinischen Geräten, der über seine Tochtergesellschaft Work (Hangzhou) Medical Treatment Equipment Co. in China tätig ist, hat die Einführung einer Dual-Class-Aktienstruktur angekündigt. Die neue Aktienstruktur tritt am 6. März 2025 in Kraft.
- None.
- Implementation of dual-class shares may reduce voting power of public shareholders
Hangzhou, China, March 05, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced the implementation of its dual-class share structure, effective March 6, 2025.
About WORK Medical Technology Group LTD
WORK Medical Technology Group LTD is a supplier of medical devices that develops and manufactures Class I and II medical devices and sells Class I and II disposable medical devices through operating subsidiaries in China. The Company has a diverse product portfolio comprising 21 products, including customized and multifunctional masks and other medical consumables. All the products have been sold in 34 provincial-level administrative regions in China, with 15 of them sold in more than 30 countries worldwide. The Company has received a number of quality-related manufacturing designations and has registered 17 products with the U.S. Food and Drug Administration allowing their products to enter the U.S. market. For more information, please visit the Company’s website: https://www.workmedtech.com/corporate.
Forward-Looking Statements
This press release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as “aims,” “anticipates,” “believes,” “could,” “estimates,” “expects,” “forecasts,” “goal,” “intends,” “may,” “plans,” “possible,” “potential,” “seeks,” “will,” and variations of these words or similar expressions that are intended to identify forward-looking statements. Any such statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements.
Any forward-looking statements in this press release are based on the Company’s current expectations, estimates and projections only as of the date of this release and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results set forth in the Company’s annual report on Form 20-F and other documents filed by the Company with the SEC. The Company explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.
For more information, please contact:
WORK Medical Technology Group LTD
Investor Relations Department
Email: ir@workmedtech.com
Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com
FAQ
When will WOK implement its dual-class share structure?
What type of company is WORK Medical Technology Group (WOK)?
What is the significance of WOK's dual-class share structure for investors?
Which stock exchange is WOK listed on?
